Upcoming Webinars & Online Events

This webinar will explore how primary human cells support drug discovery and preclinical pharmaceutical research, including toxicity and safety testing and analyzing the pharmacokinetics of new compounds.

Join our expert to explore common mAb development challenges and discover solutions to streamline workflows, reduce variability, and accelerate tech transfer.

In this webinar, Dr. Theo Roth will discuss how CRISPR-All can be used to push human genetics beyond their evolved functionality, enabling researchers to engineer synthetic cell states with therapeutic potential.

Attendees will gain insight into how these human cell-based models provide a more accurate representation of in vivo biology, and accelerate the development of safer, more effective therapies.

The drug discovery landscape is rapidly evolving with the integration of new technologies and methodologies. Returning for 2025, this event will focus on small molecule and biologic drug development, high-throughput screening and novel drug targets.

Discover end-to-end modular solutions for bispecific antibody (bsAb) design, screening, and characterization to advance next-gen therapeutics, as our expert shares insights on overcoming challenges from concept to preclinical candidates.

Join us for a two-day virtual event covering the latest analytical innovations driving efficiency, compliance and performance across pharmaceutical laboratories.